Cardiac Magnetic Resonance Imaging in Cardiomyopathies

Naim CEYLANa , Kemal DURMUŞa
aEge University Faculty of Medicine, Department of Radiology, İzmir, Türkiye

Ceylan N, Durmuş K. Cardiac magnetic resonance imaging in cardiomyopathies. In: Bayraktaroğlu S, ed. Advances in Cardiovascular System Imaging. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.54-61.

ABSTRACT
Cardiomyopathy is defined as a myocardial disease characterized by structural and functional abnormalities of the heart muscle without coronary artery disease, hypertension, valvular diseases, or congenital heart diseases. Primary cardiomyopathy refers to structural and functional disorders of the heart muscle that develop independently of other diseases. Primary cardiomyopathies can be classified phenotypically into hypertrophic, dilated cardiomyopathy, non-dilated left ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, and restrictive cardiomyopathy. Cardiac MRI (CMR), with its excellent spatial and temporal resolution, allows for simultaneous morphological and functional evaluation, making it the gold standard imaging method in the diagnosis of cardiomyopathies. CMR plays an important role in the diagnosis, treatment selection, and follow-up of cardiomyopathies. The pattern of myocardial enhancement in late gadolinium images can provide guidance regarding possible etiology and the extent of enhancement is significant for its association with poor prognostic factors such as arrhythmia and cardiac failure.

Keywords: Cardiomyopathies; magnetic resonance imaging; cardiomyopathy, hypertrophic

Referanslar

  1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classi fication of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Trans plantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-16. [Crossref]
  2. Hashimura H, Kimura F, Ishibashi-Ueda H, Morita Y, Higashi M, Nakano S, et al. Radiologic-Pathologic Correlation of Primary and Secondary Cardiomyopathies: MR Imaging and Histopathologic Findings in Hearts from Autopsy and Transplantation. RadioGraphics. 2017;37:719-36. [Crossref]
  3. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. [Crossref]
  4. McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Heart. 2017. [Crossref]
  5. Chun EJ, Choi S Il, Jin KN, Kwag HJ, Kim YJ, Choi BW, et al. Hypertrophic Cardiomyopathy: Assessment with MR Imaging and Multidetector CT. Radiographics. 2010;30:1309-28. [Crossref]
  6. Baxi AJ, Restrepo CS, Vargas D, Marmol-Velez A, Ocazionez D, Murillo H. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. Radiographics. 2016;36:335-54. [Crossref]
  7. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: Part I, MRI appearances. AJR Am J Roentgenol. 2007;189:1335-43. [Crossref]
  8. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, et al. Hypertrophic no nobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44:401-12. [Crossref]
  9. O'Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Martos R,et al. Cardiac MR imaging of non ischemic cardiomyopathies: imaging protocols and spectra of appearances. Radiology. 2012;262:403-22. [Crossref]
  10. Belloni E, De Cobelli F, Esposito A, Mellone R, Per seghin G, Canu T, et al. MRI of cardiomyopathy. AJR Am J Roentgenol. 2008;191:1702-10. [Crossref]
  11. Gupta A, Singh Gulati G, Seth S, Sharma S. Cardiac MRI in restrictive cardiomyopathy. Clin Radiol. 2012;67:95-105. [Crossref]
  12. Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, et al. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the "Working Group on myocardial and pericardial diseases" of the European Society of Cardiology Endorsed by the Indian Academy of Echocardiog. Eur Heart J Car diovasc Imaging. 2017;33:1-32. [Crossref]
  13. Rastegar N, Burt JR, Corona-Villalobos CP, te Riele AS, James CA, Murray B, et al. Cardiac MR Fin dings and Potential Diagnostic Pitfalls in Patients Evaluated for Arrhythmogenic Right Ventricular Cardiomyopathy. RadioGraphics. 2014;34:1553-70. [Crossref]
  14. Murphy DT, Shine SC, Cradock A, Galvin JM, Kee lan ET, Murray JG. Cardiac MRI in arrhythmogenic right ventricular cardiomyopathy. AJR Am J Roent genol. 2010;194:299-306. [Crossref]
  15. Norman M, Simpson M, Mogensen J, Shaw A, Hug hes S, Syrris P, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112:636-42. [Crossref]
  16. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bau ce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria. Cir culation. 2010;121:1533-41. [Crossref]
  17. Galizia MS, Attili AK, Truesdell WR, Smith ED, Helms AS, SulaimanAM, et al. Imaging Features of Arrhythmogenic Cardiomyopathies. RadioGraphics. 2024;44(4):e230154. [Crossref]
  18. Zuccarino F, Vollmer I, Sanchez G, Navallas M, Pugliese F, Gayete A. Left ventricular noncompaction: imaging findings and diagnostic criteria. AJR Am J Roentgenol. 2015;204:519-30. [Crossref]
  19. Petersen SE, Selvanayagam JB, Wiesmann F, Rob son MD, Francis JM, Anderson RH, et al. Left vent ricular non-compaction: Insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101-5. [Crossref]
  20. Fernández-Pérez GC, Aguilar-Arjona JA, De La Fuente GT, Samartín M, Ghioldi A, Arias JC, et al. Takotsubo cardiomyopathy: Assessment with cardiac MRI. AJR Am J Roentgenol. 2010;195:139-45. [Crossref]
  21. Plácido R, Cunha Lopes B, Almeida AG, Rochitte CE. The role of cardiovascular magnetic resonance in takotsub3 syndrome. J Cardiovasc Magn Reson. 2016;18:1-12. [Crossref]
  22. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850-8. [Crossref]
  23. Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020;141:1872-84. [Crossref]